Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001546043 | SCV001765488 | uncertain significance | not provided | 2020-08-10 | criteria provided, single submitter | clinical testing | In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Labcorp Genetics |
RCV001546043 | SCV002392527 | likely benign | not provided | 2023-09-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002568963 | SCV003758357 | uncertain significance | Inborn genetic diseases | 2021-11-15 | criteria provided, single submitter | clinical testing | The c.298G>T (p.V100L) alteration is located in exon 5 (coding exon 4) of the COQ8B gene. This alteration results from a G to T substitution at nucleotide position 298, causing the valine (V) at amino acid position 100 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |